Resistance-busting ICR drug enters clinical trial 19 Mar 2021 A drug discovered at The Institute of Cancer Research that could counteract drug resistance in patients with cancers including acute myeloid leukaemia has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust. Find out more Show/Hide